The H.U.B facilitates access to specialised care for treatment-resistant depression
The Jules Bordet Institute inaugurates the Novel Treatment Unit : a treatment unit in Belgium entirely dedicated to clinical trials in oncology.
Neurosurgery at the H.U.B: LITT technology confirms its clinical impact and opens the way to new indications in Belgium.
Scientists from the Jules Bordet Institute and the University of Liège develop a predictive biomarker for a rare form of leukemia
The H.U.B adopts collaborative governance in psychiatry
With “Connecting Bridge” the H.U.B aims to combat the isolation of patients with psychiatric problems.
Congenital heart disease: continuity of care, from childhood to adulthood, is a vital necessity for patients
Aphinity trial: New Progress in the treatment of HER2-positive breast cancer
A world first at the H.U.B in treating cerebral vascular malformations in newborns.
The H.U.B is proposing a special day for heart failure screening complete with an innovative test
A total immersion at Brussels University Hospital to attract new talent
Fast-track diagnosis for colorectal cancer at the H.U.B
By clicking "Subscribe" I confirm I have read and agree to the Privacy Policy.
